Evidence map›Paper›PMID 29970986›Full record

ArticleFrontiers in molecular neuroscience2018

Hyperactivity and Hypermotivation Associated With Increased Striatal mGluR1 Signaling in a Shank2 Rat Model of Autism.

Meera E Modi, Julie M Brooks, Edward R Guilmette, Mercedes Beyna, Radka Graf, Dominik Reim, Michael J Schmeisser, Tobias M Boeckers, Patricio O'Donnell, Derek L Buhl

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Role of Zinc and NMDA Receptors in Autism Spectrum Disorders.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  5. Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2022
    Review
  6. Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission.International journal of molecular sciences · 2022
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Meera E ModiPfizer Internal Medicine Research Unit, Pfizer Inc., Cambridge, MA, United States.
Julie M BrooksPfizer Internal Medicine Research Unit, Pfizer Inc., Cambridge, MA, United States.
Edward R GuilmettePfizer Internal Medicine Research Unit, Pfizer Inc., Cambridge, MA, United States.
Mercedes BeynaPfizer Internal Medicine Research Unit, Pfizer Inc., Cambridge, MA, United States.
Radka GrafPfizer Internal Medicine Research Unit, Pfizer Inc., Cambridge, MA, United States.
Dominik ReimInstitute for Anatomy and Cell Biology, Ulm University, Ulm, Germany.
Michael J SchmeisserInstitute for Anatomy and Cell Biology, Ulm University, Ulm, Germany.
Tobias M BoeckersInstitute for Anatomy and Cell Biology, Ulm University, Ulm, Germany.
Patricio O'DonnellPfizer Internal Medicine Research Unit, Pfizer Inc., Cambridge, MA, United States.
Derek L BuhlPfizer Internal Medicine Research Unit, Pfizer Inc., Cambridge, MA, United States.
Pfizer (United States) · USUniversität Ulm · DELeibniz Institute for Neurobiology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in the

Indexed as

autism spectrum disordersmGluRmotivationrat modelSHANKShank2

Identifiers

PMID29970986
PMCPMC6018399
OpenAlexW2809176595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.